Brand Capital contributed to a $35m round for the AI-based examination preparation app, which raised the money at a valuation of up to $200m.
Month: December 2018
VoxelCloud passes series B test with $50m
Tencent-backed medical diagnostics technology developer VoxelCloud has now raised $78.5m in total, Shenzhen Hongtai Capital Management having led its latest round.
SpaceX sets its sights on $500m
The GV-backed spacecraft launcher is reportedly set to raise $500m from Baillie Gifford and its existing investors at a $30.5bn valuation.
Yunding locks up $87m series D
Baidu has led a series D round for the smart device maker, whose existing investors reportedly include Fosun, Legend Star, Xiaomi and Red Star Macalline.
Luxtera lucks out with $660m Cisco acquisition
Tokyo Electron is set to exit optical transceiver producer Luxtera after Cisco has confirmed it intends to pay $660m to buy the company.
Graphcore absorbs $200m in series D funding
Microsoft, Samsung, BMW i Ventures, Robert Bosch Venture Capital and Dell Technologies Capital all invested in a round that valued the AI chipmaker at $1.7bn.
RightHand Robotics picks up $23m
The warehouse robot developer has raised cash in a series B round featuring new investor GV that boosted its total funding to $34m.
K Health diagnoses $25m series B
Comcast Ventures is among the series A investors that returned to take part in the AI-based diagnostics software startup’s series B round, bringing its overall funding to $37.5m.
Fuji Pharma fuels Alvotech with $50m
Biosimilar developer Alvotech has received $50m from Fuji Pharma through a development and commercialisation deal, valuing it at $1.19bn.
Corporates help switch on $29m industry fund
Shanghai Electric will invest $9.9m in the fund, which is targeting AI and smart manufacturing industries, while a Golden Concord subsidiary is putting up $10.2m.
News round up 17 December 2018
A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.
Eoroom brings home $174m
The smart home subsidiary of China-based Haier Group has completed a series A round led by China International Capital Corporation.
Walker catches Procter & Gamble’s eye
GV has exited POC-focused health and beauty product manufacturer Walker and Company in an acquisition of undisclosed size by Procter & Gamble.
Shanghai Cell Therapy shoots to $134m
The cancer cell therapy developer and medical services provider has closed a $134m round co-led by China Pacific and Haier Capital along with China Industrial Asset Management.